These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37208837)

  • 1. Differences in target estimands between different propensity score-based weights.
    Austin PC
    Pharmacoepidemiol Drug Saf; 2023 Oct; 32(10):1103-1112. PubMed ID: 37208837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bootstrap vs asymptotic variance estimation when using propensity score weighting with continuous and binary outcomes.
    Austin PC
    Stat Med; 2022 Sep; 41(22):4426-4443. PubMed ID: 35841200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The performance of inverse probability of treatment weighting and full matching on the propensity score in the presence of model misspecification when estimating the effect of treatment on survival outcomes.
    Austin PC; Stuart EA
    Stat Methods Med Res; 2017 Aug; 26(4):1654-1670. PubMed ID: 25934643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propensity score weighting under limited overlap and model misspecification.
    Zhou Y; Matsouaka RA; Thomas L
    Stat Methods Med Res; 2020 Dec; 29(12):3721-3756. PubMed ID: 32693715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Informing power and sample size calculations when using inverse probability of treatment weighting using the propensity score.
    Austin PC
    Stat Med; 2021 Nov; 40(27):6150-6163. PubMed ID: 34510501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On variance estimation of the inverse probability-of-treatment weighting estimator: A tutorial for different types of propensity score weights.
    Kostouraki A; Hajage D; Rachet B; Williamson EJ; Chauvet G; Belot A; Leyrat C
    Stat Med; 2024 Jun; 43(13):2672-2694. PubMed ID: 38622063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propensity score estimators for the average treatment effect and the average treatment effect on the treated may yield very different estimates.
    Pirracchio R; Carone M; Rigon MR; Caruana E; Mebazaa A; Chevret S
    Stat Methods Med Res; 2016 Oct; 25(5):1938-1954. PubMed ID: 24201469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using Balancing Weights to Target the Treatment Effect on the Treated when Overlap is Poor.
    Ben-Michael E; Keele L
    Epidemiology; 2023 Sep; 34(5):637-644. PubMed ID: 37368935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The performance of marginal structural models for estimating risk differences and relative risks using weighted univariate generalized linear models.
    Austin PC
    Stat Methods Med Res; 2024 Jun; 33(6):1055-1068. PubMed ID: 38655786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propensity score weighting analysis and treatment effect discovery.
    Mao H; Li L; Greene T
    Stat Methods Med Res; 2019 Aug; 28(8):2439-2454. PubMed ID: 29921162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addressing Extreme Propensity Scores in Estimating Counterfactual Survival Functions via the Overlap Weights.
    Cheng C; Li F; Thomas LE; Li FF
    Am J Epidemiol; 2022 May; 191(6):1140-1151. PubMed ID: 35238335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The performance of different propensity score methods for estimating marginal hazard ratios.
    Austin PC
    Stat Med; 2013 Jul; 32(16):2837-49. PubMed ID: 23239115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the use of propensity scores in case of rare exposure.
    Hajage D; Tubach F; Steg PG; Bhatt DL; De Rycke Y
    BMC Med Res Methodol; 2016 Mar; 16():38. PubMed ID: 27036963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propensity scores based methods for estimating average treatment effect and average treatment effect among treated: A comparative study.
    Abdia Y; Kulasekera KB; Datta S; Boakye M; Kong M
    Biom J; 2017 Sep; 59(5):967-985. PubMed ID: 28436047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance evaluation of regression splines for propensity score adjustment in post-market safety analysis with multiple treatments.
    Tian Y; Baro E; Zhang R
    J Biopharm Stat; 2019; 29(5):810-821. PubMed ID: 31502924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subclassification estimation of the weighted average treatment effect.
    Choi BY
    Biom J; 2021 Dec; 63(8):1706-1728. PubMed ID: 34270815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variance estimation of the risk difference when using propensity-score matching and weighting with time-to-event outcomes.
    Cafri G; Austin PC
    Pharm Stat; 2023; 22(5):880-902. PubMed ID: 37258420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Causal inference in the absence of positivity: The role of overlap weights.
    Matsouaka RA; Zhou Y
    Biom J; 2024 Jun; 66(4):e2300156. PubMed ID: 38847059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vector-based kernel weighting: A simple estimator for improving precision and bias of average treatment effects in multiple treatment settings.
    Garrido MM; Lum J; Pizer SD
    Stat Med; 2021 Feb; 40(5):1204-1223. PubMed ID: 33327037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propensity score methods and regression adjustment for analysis of nonrandomized studies with health-related quality of life outcomes.
    Cottone F; Anota A; Bonnetain F; Collins GS; Efficace F
    Pharmacoepidemiol Drug Saf; 2019 May; 28(5):690-699. PubMed ID: 30784132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.